Case ReportsMethylphenidate-Induced Awake Bruxism A Case ReportSivri, Rukiye Çolak MD; Bilgiç, Ayhan MDAuthor Information Department of Child and Adolescent Psychiatry, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey. Address correspondence and reprint requests to Rukiye Çolak Sivri, MD, Çocuk ve Ergen Psikiyatrisi AD, Meram Tıp Fakültesi, Necmettin Erbakan Üniversitesi, 42090 Meram, Konya, Turkey; E-mail: email@example.com. Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare. This work was performed at Necmettin Erbakan University, Meram School of Medicine. Clinical Neuropharmacology: March/April 2015 - Volume 38 - Issue 2 - p 60-61 doi: 10.1097/WNF.0000000000000068 Buy Metrics Abstract Methylphenidate (MPH) is a stimulant that is commonly used in the treatment of attention-deficit/hyperactivity disorder in children and adults. Several reports are available regarding the relationship of MPH use and sleep bruxism. We report the case of a 9-year-old boy who presented with severe awake bruxism after his second dose of sustained release form of MPH treatment, which was confirmed on rechallenge. This is the first report of its kind showing such relationship in the literature. Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.